Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed
Clinical trial NCT02979613 · COMPLETED
Trial details
- NCT number
- NCT02979613
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-29
- Primary completion
- 2018-09-10
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.